NASTRX

NASTRX was founded in 2004 with visions to serve the demanding field of structural biology for pharmaceutical and biotechnology companies. We are focused on providing integrated services in structural proteomics. Current services include X-ray diffraction data collection and analysis, 3-D structure determination for existing target-complex projects and de novo determination for new target projects. We specialize in customization for our clients needs... NASTRX provides innovative solutions to its clients in determination of three-dimensional structure of protein-ligand complexes and de novo protein structure services. In addition to contract crystallography services, NASTRX provides a fully integrated structural proteomic informatics solution to its clients for structure-based drug design programs.

Also known as: NASTRX, Inc.